BENCHMARK GENETICS LIMITED

• ◆

  1 PSC ceased in last 24 months

  Significant control changed hands — see the Ownership section.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. Year-on-year comparison hidden: this filing covers about 15 months versus 12 months prior. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

1. BENCHMARK GENETICS LIMITED 2014-11-14 → present
2. DE FACTO 2130 LIMITED 2014-07-03 → 2014-11-14

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the Company or to cease its operations, and as they have concluded that the Company's financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements ("the going concern period").”

Group structure

1. BENCHMARK GENETICS LIMITED · parent
   1. Benchmark Genetics Brasil 100% · Brazil · Tilapia breeding
   2. Akvaforsk Genetic Center Spring Mexico, SA de CV 100% · Mexico · Holding company
   3. Benchmark Genetics USA Inc 100% · USA · Shrimp genetics and breeding
   4. Benchmark Genetics Chile SpA 100% · Chile · Salmon breeding and genetics
   5. Benchmark Genetics Colombia SAS 100% · Colombia · Shrimp genetics and breeding
   6. Benchmark Genetics Norway AS 100% · Norway · Salmon breeding and genetics
   7. Icecod A Islandi EHF 99.32% · Iceland · Dormant
   8. Benchmark Genetics Salten AS 75% · Norway · Salmon breeding
   9. Stofnfiskur Chile Limitada 100% · Iceland · Dormant
   10. Benchmark Genetics Iceland HF 100% · Iceland · Salmon breeding and genetics
   11. Stofngen EHF 100% · Iceland · Dormant
   12. Sudourlax EHF 100% · Iceland · Dormant

Significant events

• “Completion of the deal occurred on 31 March 2025. As part of the deal the Company sold its entire shareholding in Benchmark Genetics Norway AS to Starfish Bidco AS realising a profit on disposal of £69,492,246.”
• “During the year the Directors performed a review of the carrying value of the Company's investments and group receivables. Following this review an impairment charge of £13.7m (2024: £0.7m) was made against investments and a provision of £28.2m (2024: £4.2m) was made against amounts receivable from group companies.”
• “Following the change in ownership of the Company during the period, the Company changed its accounting reference date from 30 September to 31 December so as to be aligned with the accounting reference date of its new ultimate parent undertaking Novo Nordisk Foundation.”
• “As a result of the change in ownership of the Company, the Company repaid in full the £75.9m that it owed to its previous parent undertaking Benchmark Holdings plc. Since its acquisition by Starfish Holdco AS the Company has borrowed £4.2m (2024: £73.6m) from its parent undertaking in order to support the ongoing operations of its subsidiary undertakings.”
• “On 31 March 2025 the Company filed a special resolution with Companies House confirming that the share capital of the Company be reduced from £45,000,002.00 divided into 45,000,002 ordinary shares of £1.00 each to £40,500,001.80 divided into 45,000,002 ordinary shares of £0.90 each.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.